IRCT20200623047902N16已完成未知
Bioequivalence Study of Duloxetine 30mg capsule manufactured by Sanamed company versus the originator brand in healthy volunteers
Sanamed pharma company0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 55 years（—）
- 性别
- All
入选标准
- •General Health (Liver, Heart, and Kidney)
- •Body Mass Index (18-28)
- •Informed consent
- •Age (18-55 years old)
排除标准
- •History of cardiovascular disease
- •History of liver and kidney disease
- •Alcohol and drug addiction
- •History of allergy to Duloxetine
研究者
相似试验
已完成
不适用
Bioequivalence study of Duloxetine 30 mg enteric coated capsule in 24 healthy male under fasting conditionsBioequivalence investigation of the generic Actover.Duloxetine 30 mg enteric coated capsule with brand Cymbalta® Eli Lilly capsule..IRCT20180620040164N23ACtover Pharmaceutical Co.26
尚未招募
不适用
Bioequivalence evaluation of Duloxetine Capsule 60 mg manufactured by Behin Tamin Rosamed company-.Major depressive disorder, recurrent, mildF33.0IRCT20200625047913N5Hezareh Sevom Futuristic Pharmacist24
尚未招募
不适用
Bioequivalence of DuloxetineHealthy subjects.IRCT20210201050197N1?Arya Pharmaceutical Company26
招募中
Unknown
Bioequivalence study of dapoxetine 60 mg tablet---.IRCT20230222057495N8Sami Saz Pharmaceutical Company24
招募中
Unknown
Bioequivalence study of Dapoxetine 60 mg Tablet (Pharma Chemie Pharmaceutical Company) versus Priligy ?? mg (ALZA corporation) Tablet in healthy volunteersIRCT20220111053692N12???? ???????? ????? ????24